Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Ader

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
New Microbes and New Infections|May 6, 2026
High prevalence of anal HPV16 infection among HIV-negative men who have sex with men and transgender women using pre-exposure prophylaxis: a single-centre retrospective cross-sectional studyMarion de Quillacq, Maxime Bonjour, Sarah Soueges, et al.
Tuberculosis (Edinburgh, Scotland)|June 3, 2019
Subcultured Mycobacterium tuberculosis isolates on different growth media are fully representative of bacteria within clinical samplesCharlotte Genestet, Elisabeth Hodille, Emilie Westeel, et al.
Heliyon|May 10, 2024
Rapid resistance detection is reliable for prompt adaptation of isoniazid resistant tuberculosis managementOlivier Bahuaud, Charlotte Genestet, Elisabeth Hodille, et al.
BMC Infectious Diseases|February 19, 2016
Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerSandrine Roux, Florent Valour, Judith Karsenty, et al.
Medical Mycology|September 11, 2020
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19)Damien Dupont, Jean Menotti, Jean Turc, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective studyNicolas Benech, Oana Dumitrescu, Anne Conrad, et al.
BMC Infectious Diseases|November 5, 2016
Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administrationOlivier Peeters, Tristan Ferry, Florence Ader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2019
Slowly or Nonresolving Legionnaires' Disease: Case Series and Literature ReviewCécile Pouderoux, Christophe Ginevra, Ghislaine Descours, et al.
Critical Care Medicine|May 17, 2011
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumoniaRozenn Le Berre, Sophie Nguyen, Emmanuel Nowak, et al.
Antiviral Research|September 15, 2014
Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in FranceEmilie Frobert, Sonia Burrel, Sophie Ducastelle-Lepretre, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
New Microbes and New Infections|May 6, 2026
High prevalence of anal HPV16 infection among HIV-negative men who have sex with men and transgender women using pre-exposure prophylaxis: a single-centre retrospective cross-sectional studyMarion de Quillacq, Maxime Bonjour, Sarah Soueges, et al.
Tuberculosis (Edinburgh, Scotland)|June 3, 2019
Subcultured Mycobacterium tuberculosis isolates on different growth media are fully representative of bacteria within clinical samplesCharlotte Genestet, Elisabeth Hodille, Emilie Westeel, et al.
Heliyon|May 10, 2024
Rapid resistance detection is reliable for prompt adaptation of isoniazid resistant tuberculosis managementOlivier Bahuaud, Charlotte Genestet, Elisabeth Hodille, et al.
BMC Infectious Diseases|February 19, 2016
Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerSandrine Roux, Florent Valour, Judith Karsenty, et al.
Medical Mycology|September 11, 2020
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19)Damien Dupont, Jean Menotti, Jean Turc, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective studyNicolas Benech, Oana Dumitrescu, Anne Conrad, et al.
BMC Infectious Diseases|November 5, 2016
Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administrationOlivier Peeters, Tristan Ferry, Florence Ader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2019
Slowly or Nonresolving Legionnaires' Disease: Case Series and Literature ReviewCécile Pouderoux, Christophe Ginevra, Ghislaine Descours, et al.
Critical Care Medicine|May 17, 2011
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumoniaRozenn Le Berre, Sophie Nguyen, Emmanuel Nowak, et al.
Antiviral Research|September 15, 2014
Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in FranceEmilie Frobert, Sonia Burrel, Sophie Ducastelle-Lepretre, et al.
Pageof 17